News Whistleblower lawsuit claims Takeda concealed harms of diabetes drug BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2002 (Published 13 March 2012) Cite this as: BMJ 2012;344:e2002 Article Related content Metrics Responses Peer review Related articles News FDA places greater restrictions on access to rosiglitazone Published: 24 September 2010; BMJ 341 doi:10.1136/bmj.c5287 News European regulatory body recommends suspension of rosiglitazone Published: 24 September 2010; BMJ 341 doi:10.1136/bmj.c5291 Research Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study Published: 19 August 2009; BMJ 339 doi:10.1136/bmj.b2942 See more Cardiologists’ effectiveness varies widely by region, research suggests BMJ August 10, 2022, 378 o1994; DOI: https://doi.org/10.1136/bmj.o1994 Junk food advertising bans do help reduce obesity, say researchers BMJ August 02, 2022, 378 o1930; DOI: https://doi.org/10.1136/bmj.o1930 NICE endorses new drug to prevent myocardial infarctions and strokes BMJ June 13, 2022, 377 o1444; DOI: https://doi.org/10.1136/bmj.o1444 Government pulls £100m funding for weight management services after just a year BMJ April 14, 2022, 377 o984; DOI: https://doi.org/10.1136/bmj.o984 Sixty seconds on . . . AI heart checks BMJ March 14, 2022, 376 o667; DOI: https://doi.org/10.1136/bmj.o667
